| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 06/20/2002 | US20020077357 For therapy of autoimmune disease |
| 06/20/2002 | US20020077343 H2 receptor antagonist compounds in combination with nitric oxide donors, compostions and methods of use |
| 06/20/2002 | US20020077338 HIV protease inhibitors |
| 06/20/2002 | US20020077337 Chemical compounds |
| 06/20/2002 | US20020076380 Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use |
| 06/20/2002 | DE10063023A1 Preparation of N-cyanomorpholine comprises reacting morpholine with chlorocyanide in aqueous solvent using a base |
| 06/20/2002 | DE10063008A1 Carbonsäureamidderivate Carboxamide |
| 06/20/2002 | CA2432825A1 Nonpeptide agonists and antagonists of vasopressin receptors |
| 06/20/2002 | CA2432075A1 Isolation of nucleic acids |
| 06/20/2002 | CA2431766A1 Carboxymide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 06/19/2002 | EP1215207A2 Salts of isoleucyl-thiazolidine and -pyrrolidine and their use as dipeptidylpeptidase inhibitors |
| 06/19/2002 | EP1215203A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 06/19/2002 | EP1214936A2 Use of thiazolidin- or pyrrolidin-derivatives of aminoacids as antihyperglycemic agents |
| 06/19/2002 | EP1214589A1 Method and device for detecting and isolating pharmacological compounds being contained in substance mixtures |
| 06/19/2002 | EP1214296A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 06/19/2002 | EP1214295A2 Hydroxyacetamidobenzenesulphonamide derivatives |
| 06/19/2002 | EP1214292A1 Tyrosine derivatives |
| 06/19/2002 | EP1214287A1 Amides as inhibitors for pyruvate dehydrogenase |
| 06/19/2002 | EP0841340B1 Substituted benzenedithiol-metal complexes |
| 06/19/2002 | CN1354740A Pharmaceutical compounds |
| 06/19/2002 | CN1354737A Novel derivatives of 3-3-diphenylpropylamines |
| 06/19/2002 | CN1354175A Preparation method of carbonyl alpha-substitution nitrogenous compound |
| 06/19/2002 | CN1354174A Synthesis of triethylene diamine and piperazine by using modified zeolite catalyst |
| 06/19/2002 | CN1086387C N-(aryloxyalkyl)heteroarylpiperidines and heteroarylpiperazines, their preparing method and their use as medicine |
| 06/18/2002 | US6407120 Administering pyridinylacetamide or phenylacetamide derivative to treat cardiovascular, eating, sexual, brain, nervous system, gastrointestinal, urogenital, psychological, and respiratory system disorders |
| 06/18/2002 | US6407113 2-(1-piperazinyl)-5-methylbenzenesulfonic acid derivative or its salt, or hydrate or solvate; improve abnormal intracellular handling calcium ion |
| 06/18/2002 | US6407111 Phenyl substituted pyridine and benzene derivatives |
| 06/18/2002 | US6407107 4-(morpholino)alkyl butanamide derivatives; autoimmune diseases; anticarcinogenic agents |
| 06/18/2002 | US6407099 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same |
| 06/18/2002 | US6407081 Administering azobisformamide or azobisformamidine derivative to inhibit interleukins, interferons and tumor necrosis factor |
| 06/18/2002 | US6407070 Mixture containing granulation agent; therapy for kidney disease |
| 06/18/2002 | US6407064 Aminoalcohol derivative and medicament comprising the same |
| 06/13/2002 | WO2002046149A2 2-thio-5-amino substituted benzoquinones, their manufacture and their use in rubber |
| 06/13/2002 | WO2002046144A1 Tetralone derivatives as antitumor agents |
| 06/13/2002 | WO2002046139A2 1,7 and 1,9-diarylpolymethine salts |
| 06/13/2002 | WO2002046134A1 Novel estrogen receptor ligands and methods iii |
| 06/13/2002 | WO2002046129A2 Inhibitors of histone deacetylase |
| 06/13/2002 | WO2002045715A1 Nootropic effect enhancer |
| 06/13/2002 | WO2002018334A3 Sodium channel modulators |
| 06/13/2002 | WO1999059957A9 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 06/13/2002 | US20020072529 For therapy and prophylaxis of cerebral apoplexy and craniocerebral trauma |
| 06/13/2002 | US20020072520 For use in therapy of hyperlipidemia and arteriosclerotic disorders |
| 06/13/2002 | US20020072516 For therapy of diabetes, obesity, autoimmune disorders, acute and chronic inflammatory disorders, osteoporosis, cancer, malignant disorders |
| 06/13/2002 | CA2431181A1 Nootropic effect enhancer |
| 06/13/2002 | CA2430769A1 Novel estrogen receptor ligands and methods iii |
| 06/13/2002 | CA2430355A1 Tetralone derivatives as antitumor agents |
| 06/12/2002 | EP1213280A2 A process for the preparation of amine oxides |
| 06/12/2002 | EP1212302A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 06/12/2002 | EP1212296A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 06/12/2002 | EP1212292A1 (-)-verbenone derivatives |
| 06/12/2002 | EP1212269A1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds |
| 06/12/2002 | EP1032571B1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 06/12/2002 | EP0984778B1 Neuropeptide-y ligands |
| 06/12/2002 | EP0970040B1 Method for producing n-carboxyalkyl-3-fluoro-4-dialkylaminonilines |
| 06/12/2002 | EP0966437B1 5-aroylnaphthalene derivatives |
| 06/12/2002 | EP0932657B1 Asymmetrical bleach activators and compositions employing the same |
| 06/12/2002 | EP0929517B1 Hydroxamic acid derivatives |
| 06/12/2002 | EP0927173B1 substituted [2-(1-piperazinyl)ethoxy]methyl |
| 06/12/2002 | EP0885204B1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 06/12/2002 | EP0751939B1 Naphthylamides as central nervous system agents |
| 06/12/2002 | CN1353702A Adamantane derivatives |
| 06/12/2002 | CN1353697A 4-phenyl-pyrimidine derivatives |
| 06/12/2002 | CN1353696A 5-phenyl-pyrimidine derivatives |
| 06/12/2002 | CN1353691A Cell adhesion-inhibiting anti inflammatory and immune-suppresive compounds |
| 06/12/2002 | CN1353690A Bradykinin receptor antagonists |
| 06/12/2002 | CN1353688A Compounds derived from benzoic acid esters, composition comtaining said compounds and use thereof |
| 06/11/2002 | US6403818 Process for producing α-hydroxy-carbonyl compound |
| 06/11/2002 | US6403802 Use of catalyst system comprising nickel, palladium, or platinum and imidazoline-2-ylidene or imidazolidine-2-ylidene in amination reactions |
| 06/11/2002 | US6403774 Azoamidine compound |
| 06/11/2002 | US6403611 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/11/2002 | US6403607 Sulfonamide derivatives and drugs containing the same as the active ingredient |
| 06/11/2002 | US6403600 Fungicides. |
| 06/11/2002 | US6403589 Nucleoside transport inhibitor |
| 06/11/2002 | US6403577 Hexamethyleneiminyl tachykinin receptor antagonists |
| 06/11/2002 | CA2198578C Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/06/2002 | WO2002044160A1 Pancreatitis remedies and medicines for prevention and therapy of reflux esophagitis |
| 06/06/2002 | WO2002044159A2 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatment of incontinence |
| 06/06/2002 | WO2002044139A1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 06/06/2002 | WO2002044119A2 Synthesis of 2-aryl-1-naphthol derivatives via a tandem palladium catalyzed arylation and dehydrogenation |
| 06/06/2002 | WO2002044113A2 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 06/06/2002 | WO2002043648A2 Compounds active at the glucocorticoid receptor ii |
| 06/06/2002 | WO2002007683B1 Antimicotic nail varnish composition |
| 06/06/2002 | WO2002004406A3 9-substituted minocycline compounds |
| 06/06/2002 | WO2001087849A3 Modulators of tnf- alpha signaling |
| 06/06/2002 | WO2001083567A3 Nitroaromatic solubilizer for nitroxyls in aromatic solvents |
| 06/06/2002 | WO2001068643A3 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 06/06/2002 | US20020068838 Such as 4-(3-(3,4-dichlorophenyl)-2-fluoropropyl)-N-(2-methyl -phenyl)-benzamide |
| 06/06/2002 | US20020068731 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 06/06/2002 | CA2430311A1 Compounds active at the glucocorticoid receptor ii |
| 06/06/2002 | CA2430199A1 Use of(-) (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia |
| 06/06/2002 | CA2427098A1 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatment of incontinence |
| 06/05/2002 | EP1211247A1 Acylamino cyclopropane derivatives |
| 06/05/2002 | EP1210941A2 Pharmaceutical compositions containing ritonavir (ABT-538) in combination with indinavir (MK-639) and their use for treating AIDS |
| 06/05/2002 | EP1210353A1 Calcium complex of phosphorus containing ethylenediamine derivatives |
| 06/05/2002 | EP1210340A1 Substituted piperazine derivatives, the production thereof and their utilization as medicaments |
| 06/05/2002 | EP1210330A1 Antibacterial agents |
| 06/05/2002 | EP0937054B1 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications |
| 06/05/2002 | EP0752866B1 Medicaments for treating restenosis, comprising nitric oxide releasing polymers |
| 06/05/2002 | EP0722319B1 Anthracyclinone derivatives and their use in amyloidosis |
| 06/05/2002 | CN1352636A Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |